PRIA Logo™
DelawareSS 1 for SJR 7 w/ HA 1153rd General Assembly (2024–2026)SenateWALLET

DIRECTING THE STATE EMPLOYEE BENEFITS COMMITTEE AND THE SECRETARY OF HUMAN RESOURCES TO ENGAGE WITH INDEPENDENT CONSULTANTS AND OTHER SUPPLY CHAIN TACTICS FOR COST CONTAINMENT OF PRESCRIPTION DRUGS FOR STATE EMPLOYEES AND RETIREES’ INSURANCE PROGRAMS.

Sponsored By: Ray Seigfried (Democratic)

Signed by Governor

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

3 provisions identified: 3 benefits, 0 costs, 0 mixed.

Independent drug list for state health plans

The law creates an independent Pharmacy and Therapeutics committee for the state plans. It sets and reviews the drug list for state employees and retirees. The consultant who advises the list is paid to find the lowest-cost options. They must recommend generics when there is no added benefit from a brand drug. This helps control plan costs and can lower what you pay at the pharmacy.

Stronger drug price bargaining for state plans

The law requires active price bargaining for state drug coverage. The SEBC uses tools like reverse auctions and other supply-chain tactics to cut costs. PBMs must bid using the lowest available price for each drug, not the average wholesale price. The State does not pay more than Medicare’s negotiated price when Medicare has one. Delaware can also join other states to negotiate directly with drug makers for very expensive medicines.

More PBM transparency and audits for state plans

The law gives the State stronger oversight of drug spending. The State owns and uses real-time point-of-sale drug price data. PBMs that work with the State must disclose all their administrative fees. The SEBC can see PBM contracts with drug makers for covered drugs. The State can audit these records and hire outside auditors to check for overcharges.

Sponsors & Cosponsors

Sponsor

  • Ray Seigfried

    Democratic • Senate

Cosponsors

  • Eric Buckson

    Republican • Senate

  • Stephanie L. Hansen

    Democratic • Senate

  • Jeff Hilovsky

    Republican • House

  • Melissa Minor-Brown

    Democratic • House

  • Edward S. Osienski

    Democratic • House

  • Marie Pinkney

    Democratic • Senate

  • David P. Sokola

    Democratic • Senate

  • Bryan Townsend

    Democratic • Senate

  • John "Jack" Walsh

    Democratic • Senate

  • David L. Wilson

    Republican • Senate

Roll Call Votes

All Roll Calls

Yes: 79 • No: 0

Senate vote • 7/1/2025

Passed (SM required)

Yes: 21 • No: 0

House vote • 7/1/2025

Passed (SM required)

Yes: 39 • No: 0

Senate vote • 5/21/2025

Passed (SM required)

Yes: 19 • No: 0

Actions Timeline

  1. Signed by Governor

    8/25/2025Governor

  2. Passed By Senate. Votes: 21 YES

    7/1/2025Senate

  3. Suspension of Rules in Senate

    7/1/2025Senate

  4. Passed By House. Votes: 39 YES 1 ABSENT 1 VACANT

    6/30/2025House

  5. Amendment HA 1 to SS 1 - Passed In House by Voice Vote

    6/30/2025House

  6. Reported Out of Committee (Administration) in House with 5 On Its Merits

    6/25/2025House

  7. Not Worked in Committee

    6/18/2025Senate

  8. Not Worked in Committee

    6/11/2025Senate

  9. Assigned to Administration Committee in House

    5/22/2025House

  10. Passed By Senate. Votes: 19 YES 2 ABSENT

    5/21/2025Senate

  11. was introduced and adopted in lieu of SJR 7

    5/21/2025Senate

Bill Text

  • Current

    5/21/2025

    HTML

Related Bills

Back to State Legislation